Day: July 13, 2022

Ásgeir Helgi Reykfjörð Gylfason has assumed the position of CEO of SKEL fjárfestingafélag hf. and Magnus Ingi Einarsson as CFO. Auður Daníelsdóttir has also started as CEO of Orkan IS ehf., SKEL’s subsidiary. For further information, please contact Ásgeir Helgi Reykfjörð Gylfason (fjarfestar@skel.is) www.skel.is 

Eli Lilly and Co has the highest number of type 2 diabetes drugs in development LONDON, July 13, 2022 (GLOBE NEWSWIRE) — The “Type 2 Diabetes (Metabolic Disorder) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2021 Update” report offered by Globaldata provides comprehensive information on the therapeutics under development for Type 2 Diabetes, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Type 2 Diabetes and features dormant and discontinued projects. Type...

WithSecure Corporation, Press Release, 13 July 2022, at 11:00 EEST WithSecure to publish January – June 2022 half-year report on 20 July 2022 WithSecure Corporation will publish its January-June 2022 (Q2 2022) half-year report on Wednesday 20 July 2022 at approximately 08:00 EEST. WithSecure’s CEO Juhani Hintikka and CFO Tom Jansson will present the results in a webcast starting at 13:00 EEST. The webcast will be held in English and can be accessed at https://withsecure.videosync.fi/2022-07-20-wsirq2/. Questions are requested in written format in the webcast portal. Analysts following WithSecure are invited to the presentation at the company headquarters, Tammasaarenkatu 7, Helsinki, Finland. The presentation material and the webcast recording will be available on the company’s website at https://www.withsecure.com/en/about-us/investor-relations. Contact...

Philips MR imagingPhilips MR 7700Philips SmartSpeed MR softwareSpectral CT product side viewJuly 13, 2022  Philips demonstrates portfolio of smart connected imaging systems and integrated radiology workflow solutions designed to improve diagnostic confidence and clinical outcomes Amsterdam, the Netherlands and Vienna, Austria – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, will showcase its award-winning AI-powered systems and solutions debuting at the European Congress of Radiology (ECR, July 13-17, Vienna, Austria).  Philips will demonstrate how its portfolio of smart connected imaging systems and integrated radiology workflow solutions help increase diagnostic confidence and clinical outcomes; help reduce staff stress and burnout; improve patient engagement and quality access to care; and...

Bids, sales, stop-rates and prices are presented in the table below:      ISIN Bid Mill. kr. (nominal) Sale Stop-rate (per cent) Pro-rata Price98 18692 DKT 01/09/22 III 2,300 2,300 -0.495 100 % 100.066098 18775 DKT 01/12/22 IV 500 500 -0.100 100 % 100.0386Total 2,800 2,800      The sale will settle 15 July 2022

The global TMT M&A market saw 39 M&A deals in Q1 2022 with a deal size greater than $1 billion LONDON, July 13, 2022 (GLOBE NEWSWIRE) — The “Tech, Media, and Telecom (TMT) Industry Mergers and Acquisitions Deals by Top Themes in Q1 2022 – Thematic Research” report offered by GlobalData Plc analyzes the disruptive themes that have driven M&A activity in Q1 2022 in the TMT Sector. The metaverse is defined as a virtual world where users share experiences and interact in real-time within simulated scenarios. Big tech is busy developing the metaverse, which could transform how people work, shop, interact, and consume content. Companies investing in the metaverse will increasingly focus on themes, including artificial intelligence (AI), augmented reality (AR), virtual reality (VR), 5G, and cloud computing. Tech giants...

BRISBANE, Australia, July 13, 2022 (GLOBE NEWSWIRE) — Allkem Limited (ASX|TSX: AKE) (“Allkem” or “the Company”) will release its June Quarter Activities Report on Wednesday, 20 July 2022. Managing Director and CEO, Mr. Martín Pérez de Solay and Chief Sales and Marketing Officer, Christian Barbier will conduct a live webcast briefing at 10:00 am AEST (Brisbane, Sydney, Melbourne) on the same day. To pre-register your details and join the webcast briefing, please follow the link on the homepage of Allkem’s website, www.allkem.co. Written questions may be submitted via the webcast and playback of the briefing and Q&A session will also be available on the company’s website. This release was authorised by Mr. Martin Perez de Solay, CEO and Managing Director of Allkem Limited.Allkem Limited ABN 31 112 589 910 Level 35, 71 Eagle...

Company announcement 10/2022 Green Hydrogen Systems A/S – Notification of transactions by persons discharging managerial responsibilities in Green Hydrogen Systems A/S Kolding, Denmark, 13 July 2022 – In accordance with article 19 of the Market Abuse Regulation, Green Hydrogen Systems A/S (“Green Hydrogen Systems”) hereby notifies receipt of information of the following transactions made by persons discharging managerial responsibilities in Green Hydrogen Systems and persons closely associated with them in Green Hydrogen Systems’ shares and other financial instruments linked thereto in connection with the exercise and cash settlement of warrants: 1.Details of the person discharging managerial responsibilities/person closely associateda) Name: Thyge Boserup2.Reason for the notificationa) Position/status: Member of the board of directors...

Roche group’s Genentech emerged as the market leader in the HER2+ breast cancer drugs market in 2020 LONDON, July 13, 2022 (GLOBE NEWSWIRE) — The “HER2+ Breast Cancer – Global Drug Forecast and Market Analysis to 2030” report offered by GlobalData provides opportunities for various marketed agents and pipeline agents in development across the 8MM, clinical and commercial assessments for agents in late-stage clinical development, R&D strategies, and innovative approaches in development for HER2+ breast cancer. The sales of HER2+ breast cancer therapies in the 8MM were estimated at $10.4 billion in 2020 and is expected to increase at a CAGR of more than 1% during the forecast period. Global sales are dominated by the US due to its large patient population and higher cost of therapy in the country.To get comprehensive statistics...

Maha Energy AB (publ) (“Maha” or the “Company”) is pleased to announce that the recently completed Tie-5 well is now producing through the Tie field’s permanent production facilities.  The well is naturally flowing, without the assistance of an Electrical Submersible Pump (“ESP”), 766 BOEPD1 (590 BOPD and 1,054 MSCFPD) with a stable tubing-head flowing pressure of 220 psi and less than 1% water. The corporate annual average production guidance of 4,000 – 5,000 BOEPD for 2022 remains. The Tie-5 horizontal well penetrated 240 meter of Agua Grande (AG) sand and was completed with a 4-1/2” uncemented pre-perforated liner to 2,409 m. A coil tubing unit was used to clean up and then stimulate the reservoir before blowing the well dry using nitrogen. An ESP was run in the hole on 3-1/2” tubing and the well immediately responded by flowing...